Spero Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
6.33
|
|
Average Rating
|
4.25
|
|
# Strong Buys
|
2
|
|
# Buys
|
1
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.30
|
-0.33
|
-0.03
|
-10.00%
|
|
2022-06-30
|
-0.93
|
-0.87
|
0.06
|
6.45%
|
|
2022-03-31
|
-0.87
|
-1.01
|
-0.14
|
-16.09%
|
|
2021-12-31
|
-0.75
|
-0.90
|
-0.15
|
-20.00%
|
|
2021-09-30
|
-0.66
|
-0.70
|
-0.04
|
-6.06%
|
|
2021-06-30
|
-0.75
|
-0.63
|
0.12
|
16.00%
|
|
2021-03-31
|
-0.64
|
-0.66
|
-0.02
|
-3.13%
|
|
2020-12-31
|
-0.74
|
-0.68
|
0.06
|
8.11%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.21
|
|
2021-12-31
|
-2.89
|
|
2020-12-31
|
-3.58
|
|
2019-12-31
|
-3.30
|
|
2018-12-31
|
-42.97
|